FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W47465366> ?p ?o ?g. }

• W47465366 abstract "Breast cancer has the highest incidence rate amongst female cancers worldwide. Following the advent of mammography and the utilization of advanced treatment strategies breast cancer mortality rates have markedly declined. However, in order to treat the refractory and more aggressive forms of the disease, development of detection methods using novel biomarkers and more efficacious therapeutic protocols are still needed. P53 dysfunction and impaired p53 signalling has been reported in over 50% of human cancers. Impairment of p53 activity in various cancers has primarily been attributed to P53 gene mutations. In addition to gene mutations, however, alterations in the activity of upstream and/or downstream TP53 regulators (e.g. autoregulatory loops, proteins and miRNAs) also modulate the activity of the p53 pathway. The frequency of p53 mutations in breast cancer is lower than other cancers (approximately 20%). The impact of these additional p53 regulatory mechanisms on breast cancer pathology is poorly understood. To address this issue, the present study examined the following: I. Identify novel mechanisms of p53 pathway inactivation in breast cancer, independent of P53 gene mutations.II. Establish an association between aberrant DNA methylation of p53 regulatory pathways and downstream p53 activity. III. Evaluate differences in aberrant DNA methylation signatures between primary tumors and metastatic lesions and its contribution to pathology. In the first part of the study, we demonstrated that both P14ARF and PTEN (P <0.05 and P <0.01, respectively) promoters were hypermethylated in breast cancer patients. Hypermethylation of both promoters could potentially mediate p53 inactivation via the dysregulation of p53 auto-regulatory feedback loops. Indeed, proteomic characterization of breast cancer cell lines upon demethylation therapy revealed the overexpression of p53 regulatory proteins - Atic, Calr and Pcna. This indicates a putative role of DNA methylation on the regulation of p53 pathway activity. Furthermore, we identified a subset of differentially expressed miRNAs that targeted p53 pathway components. In this context, over-expression of miR-21 (P<0.05) is potentially important for the pathogenesis of wt-p53 breast cancer patients. Second, we were able to demonstrate a significant correlation between the hypermethylation of P16/Rb and P53/P21 promoters and the shortening of telomere length in breast cancer patients (r=-0.33, P=0.001; r=-0.70, P<0.0001 and r=-0.71, P<0.0001; respectively). Moreover, hypermethylation of P14ARF and PTEN was associated with increased mitochondrial DNA (mt-DNA) damages including: depletion of mt-DNA content (11.88-fold changes; P< 0.01) and enhancement of mutations in the D-loop region (36.36%). Lastly, we explored the methylation signature of 12 breast cancer candidate genes (APC, BIN1, BMP6, BRCA1, CST6, ESR-b, GSTP1, P14, P16, P21, PTEN and TIMP3). There was considerable heterogeneity in the methylation status of primary tumors and metastatic lesions. Higher methylation levels at promoter regions of APC, BIN1, BMP6, BRCA1, CST6, ESR-b, P16, PTEN and TIMP3 were identified in primary tumor tissues (P<0.05, P<0.05, P<0.01, P<0.0001, P<0.01, P<0.01, P<0.05, P<0.05, P<0.01; respectively), whereas in metastatic lymph node lesions only BMP6, BRCA1 and P16 were hypermethylated (P<0.05 and P<0.01, P<0.0001, P<0.05; respectively). In conclusion, the present study identified novel biomarkers for tumor specific and metastatic breast cancers. Aberrant methylation signature of APC, BIN1, BMP6, BRCA1, CST6, ESR-b, GSTP1, P14ARF, P16, P21, PTEN and TIMP3, as well as overexpression of miR-21, increased mt-DNA damages and shortened telomere length specifically identified tumor specific lesions. Moreover, hypermethylation of BMP6, BRCA1 and P16 gene promoters indicate their potential use as metastatic biomarkers. These novel biomarkers will be further examined for the effect of specific hypermethylated CpG sites on the transcriptional activity of each gene. Furthermore, establishing absolute percent methylation cutoffs for each breast tumor sub-type would enable their utilization in clinical laboratory settings." @default.
• W47465366 created "2016-06-24" @default.
• W47465366 creator A5064558292 @default.
• W47465366 date "2013-01-01" @default.
• W47465366 modified "2023-09-26" @default.
• W47465366 title "P53 pathway alterations in breast cancer for biomarker discovery" @default.
• W47465366 doi "https://doi.org/10.5451/unibas-006116264" @default.
• W47465366 hasPublicationYear "2013" @default.
• W47465366 type Work @default.
• W47465366 sameAs 47465366 @default.
• W47465366 citedByCount "0" @default.
• W47465366 crossrefType "dissertation" @default.
• W47465366 hasAuthorship W47465366A5064558292 @default.
• W47465366 hasConcept C104317684 @default.
• W47465366 hasConcept C121608353 @default.
• W47465366 hasConcept C126322002 @default.
• W47465366 hasConcept C143998085 @default.
• W47465366 hasConcept C145059251 @default.
• W47465366 hasConcept C150194340 @default.
• W47465366 hasConcept C190727270 @default.
• W47465366 hasConcept C2776750431 @default.
• W47465366 hasConcept C2777609662 @default.
• W47465366 hasConcept C2778264664 @default.
• W47465366 hasConcept C2781197716 @default.
• W47465366 hasConcept C41091548 @default.
• W47465366 hasConcept C502942594 @default.
• W47465366 hasConcept C530470458 @default.
• W47465366 hasConcept C54355233 @default.
• W47465366 hasConcept C555283112 @default.
• W47465366 hasConcept C62478195 @default.
• W47465366 hasConcept C71924100 @default.
• W47465366 hasConcept C86554907 @default.
• W47465366 hasConcept C86803240 @default.
• W47465366 hasConceptScore W47465366C104317684 @default.
• W47465366 hasConceptScore W47465366C121608353 @default.
• W47465366 hasConceptScore W47465366C126322002 @default.
• W47465366 hasConceptScore W47465366C143998085 @default.
• W47465366 hasConceptScore W47465366C145059251 @default.
• W47465366 hasConceptScore W47465366C150194340 @default.
• W47465366 hasConceptScore W47465366C190727270 @default.
• W47465366 hasConceptScore W47465366C2776750431 @default.
• W47465366 hasConceptScore W47465366C2777609662 @default.
• W47465366 hasConceptScore W47465366C2778264664 @default.
• W47465366 hasConceptScore W47465366C2781197716 @default.
• W47465366 hasConceptScore W47465366C41091548 @default.
• W47465366 hasConceptScore W47465366C502942594 @default.
• W47465366 hasConceptScore W47465366C530470458 @default.
• W47465366 hasConceptScore W47465366C54355233 @default.
• W47465366 hasConceptScore W47465366C555283112 @default.
• W47465366 hasConceptScore W47465366C62478195 @default.
• W47465366 hasConceptScore W47465366C71924100 @default.
• W47465366 hasConceptScore W47465366C86554907 @default.
• W47465366 hasConceptScore W47465366C86803240 @default.
• W47465366 hasLocation W474653661 @default.
• W47465366 hasOpenAccess W47465366 @default.
• W47465366 hasPrimaryLocation W474653661 @default.
• W47465366 hasRelatedWork W1969571658 @default.
• W47465366 hasRelatedWork W1999572070 @default.
• W47465366 hasRelatedWork W2049153941 @default.
• W47465366 hasRelatedWork W2063836248 @default.
• W47465366 hasRelatedWork W2068078598 @default.
• W47465366 hasRelatedWork W2071541442 @default.
• W47465366 hasRelatedWork W2087444061 @default.
• W47465366 hasRelatedWork W2097802504 @default.
• W47465366 hasRelatedWork W2108246461 @default.
• W47465366 hasRelatedWork W2120653843 @default.
• W47465366 hasRelatedWork W2121814485 @default.
• W47465366 hasRelatedWork W2136841701 @default.
• W47465366 hasRelatedWork W2193969951 @default.
• W47465366 hasRelatedWork W2223833120 @default.
• W47465366 hasRelatedWork W2314328867 @default.
• W47465366 hasRelatedWork W25601078 @default.
• W47465366 hasRelatedWork W2801225198 @default.
• W47465366 hasRelatedWork W3007612800 @default.
• W47465366 hasRelatedWork W3032586193 @default.
• W47465366 hasRelatedWork W3028982224 @default.
• W47465366 isParatext "false" @default.
• W47465366 isRetracted "false" @default.
• W47465366 magId "47465366" @default.
• W47465366 workType "dissertation" @default.